✦ LIBER ✦

Preclinical pharmacokinetic/pharmacodynamic/efficacy relationships for alisertib, an investigational small-molecule inhibitor of Aurora A kinase

✍ Scribed by Palani, Santhosh; Patel, Mayankbhai; Huck, Jessica; Zhang, Mengkun; Balani, Suresh K.; Yang, Johnny; Chen, Susan; Mettetal, Jerome; Manfredi, Mark; Shyu, Wen Chyi; Ecsedy, Jeffrey A.; Chakravarty, Arijit

Book ID: 121602463
Publisher: Springer
Year: 2013
Tongue: English
Weight: 365 KB
Volume: 72
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-013-2305-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

256 Mechanism-based Preclinical PK/PD/E

256 Mechanism-based Preclinical PK/PD/E Relationships for Alisertib, an Investigational Small-molecule Inhibitor of Aurora A Kinase, in a Range of Human Solid Tumor Xenografts

✍ Palani, S.; Patel, M.; Zhang, M.; Balani, S.; Mettetal, J.; Manfredi, M.; Venkat 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Translational Exposure-Efficacy Modeling

Translational Exposure-Efficacy Modeling to Optimize the Dose and Schedule of Taxanes Combined with the Investigational Aurora A Kinase Inhibitor MLN8237 (Alisertib)

✍ Huck, J. J.; Zhang, M.; Mettetal, J.; Chakravarty, A.; Venkatakrishnan, K.; Zhou 📂 Article 📅 2014 🏛 American Association for Cancer Research 🌐 English ⚖ 1003 KB

93 POSTER Phase I assessment of mechanis

93 POSTER Phase I assessment of mechanistic pharmacodynamic biomarkers for MLN8054, a small-molecule inhibitor of Aurora A kinase

✍ A. Chakravarty; V.B. Shinde; K. Galvin; L. Silverman; B. Stringer; H. Danaee; O. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 56 KB